Literature DB >> 105657

Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use.

J Aisner, J Murillo, S C Schimpff, A C Steere.   

Abstract

Aspergillosis in cancer patients is a problem. Because not all patients can undergo invasive procedures, we sought other methods for diagnosis. We reviewed the data from all patients with acute nonlymphocytic leukemia treated at our center during a 3-year period. Of 125 patients, 18 had invasive aspergillosis (cases). Eleven patients had nose cultures growing Aspergillus flavus or A. fumigatus; 10 of these 11 had aspergillosis, whereas only eight of 114 without such nose cultures had invasive disease (P less than 0.000001). Thus, A. flavus on nose culture appears "predictive" for aspergillosis. Absence of such a culture does not preclude infection. Of 125 patients, 61 had sterile nose culture(s) and 14 of the 18 cases had such a sterile nose culture. Only four of the 64 patients without sterile nose cultures developed aspergillosis (P less than 0.008), suggesting a relation between sterile nose culture and aspergillosis. Carbenicillin was used for a longer period among cases and patients with predictive nose cultures than among patients without aspergillosis. These data may help identify patients at risk of aspergillosis and help determine antifungal therapy when invasive procedures are contraindicated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 105657     DOI: 10.7326/0003-4819-90-1-4

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  30 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Sinusitis in the Immunocompromised Host.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

3.  Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work.

Authors:  A G Dewhurst; M J Cooper; S M Khan; A P Pallett; J R Dathan
Journal:  BMJ       Date:  1990-10-06

Review 4.  Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.

Authors:  Anna B Halpern; Gary H Lyman; Thomas J Walsh; Dimitrios P Kontoyiannis; Roland B Walter
Journal:  Blood       Date:  2015-10-26       Impact factor: 22.113

5.  Development of a chromosomal DNA probe for the laboratory diagnosis of aspergillosis.

Authors:  M A Gabal
Journal:  Mycopathologia       Date:  1989-05       Impact factor: 2.574

6.  Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: a single center experience from 1980 to 1995.

Authors:  A De Laurenzi; A Matteocci; A Lanti; L Pescador; F Blandino; C Papetti
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

7.  Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Authors:  V Chazalet; J P Debeaupuis; J Sarfati; J Lortholary; P Ribaud; P Shah; M Cornet; H Vu Thien; E Gluckman; G Brücker; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Molecular epidemiology of nosocomial invasive aspergillosis.

Authors:  H Girardin; J Sarfati; F Traoré; J Dupouy Camet; F Derouin; J P Latgé
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Aspergillus granuloma of the trigeminal ganglion.

Authors:  C M Wiles; R S Kocen; L Symon; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

10.  Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients.

Authors:  J J Weems; A Andremont; B J Davis; C H Tancrede; M Guiguet; A A Padhye; F Squinazi; W J Martone
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.